Hera Med Ltd
ASX:HMD

Watchlist Manager
Hera Med Ltd Logo
Hera Med Ltd
ASX:HMD
Watchlist
Price: 0.043 AUD Market Closed
Market Cap: AU$44.9m

Net Margin

-960.6%
Current
Improving
by 29%
vs 3-y average of -989.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-960.6%
=
Net Income
$-4.5m
/
Revenue
$322.9k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-960.6%
=
Net Income
AU$-4.5m
/
Revenue
$322.9k

Peer Comparison

Country Company Market Cap Net
Margin
IL
Hera Med Ltd
ASX:HMD
44.9m AUD
Loading...
US
Abbott Laboratories
NYSE:ABT
190.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
140.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.4B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...

Market Distribution

Lower than 95% of companies in Israel
Percentile
5th
Based on 749 companies
5th percentile
-960.6%
Low
-85 210% — -8.6%
Typical Range
-8.6% — 7.2%
High
7.2% — 23 652.1%
Distribution Statistics
Israel
Min -85 210%
30th Percentile -8.6%
Median 1.8%
70th Percentile 7.2%
Max 23 652.1%

Hera Med Ltd
Glance View

Market Cap
44.9m AUD
Industry
Health Care

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

HMD Intrinsic Value
0.001 AUD
Overvaluation 97%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-960.6%
=
Net Income
$-4.5m
/
Revenue
$322.9k
What is Hera Med Ltd's current Net Margin?

The current Net Margin for Hera Med Ltd is -960.6%, which is above its 3-year median of -989.6%.

How has Net Margin changed over time?

Over the last 3 years, Hera Med Ltd’s Net Margin has increased from -2 395.3% to -960.6%. During this period, it reached a low of -2 395.3% on May 30, 2022 and a high of -761.2% on Dec 31, 2023.

Back to Top